The price of Radix ginseng fell, and the pressure on the cost of raw materials of Jiangzhong Pharmaceutical was relieved!

　　The 2021 annual report released by Jiangzhong Pharmaceutical Co.
, Ltd.
(hereinafter referred to as "Jiangzhong Pharmaceutical") shows that during the reporting period, the company achieved operating income of 2.
874 billion yuan, a year-on-year increase of 17.
72%; net profit attributable to owners of the parent company was 5.
06 100 million yuan, a year-on-year increase of 6.
74%
.
Figure 1: Jiangzhong Pharmaceutical's core business data from 2016 to 2021 1.
The terminal digestive system of urban pharmacies exceeded 14 billion Chinese patent medicines Figure 2: The sales of Chinese patent medicines in the terminal digestive system of physical pharmacies in China in recent years (unit: 100 million yuan Source: Minet.
com ) According to data from Minet.
com, in recent years, the Chinese patent medicine market for the terminal digestive system of physical pharmacies in China has maintained steady growth, with sales exceeding 14 billion yuan in 2020 and a new high in 2021, with a year-on-year increase of 3.
11%
.
Among the 13 sub-categories of Chinese patent medicines for the digestive system, the five sub-categories are the best-selling medicines, namely, stomach and digestion medicines (gastritis, ulcers), heat-removing medicines, liver disease medicines, and hemorrhoid medicines, with a total market share of nearly 80%
.
It is worth noting that gastric medicines (gastritis, ulcers) have been the largest subcategory of Chinese patent medicines in the digestive system for many years
.
2.
Jiangzhong Pharmaceutical No.
1 in the field of stomach and digestion The main products of Jiangzhong Pharmaceutical are Jianwei Xiaoshi Tablets, Lactobacillus Tablets, Compound Grass Coral Tablets, Bezoar Shedan Chuanbei Liquid, Fenghanmao Granules, Xia Sangju Granules, Chuanbei Loquats capsules,
etc.
Table 1: Production and sales of Jiangzhong Pharmaceutical's main products in 2021 (source: corporate annual report) According to the data of Minet, Jianwei Xiaoshi tablets have grown steadily in the terminal sales of physical pharmacies
in Chinese cities in recent years, and will exceed the 1.
5 billion mark in 2021 .
At present, there are more than 40 manufacturers of Jianwei Xiaoshi tablets, of which Jiangzhong Pharmaceutical has the largest market share, accounting for more than 90%
.
Table 2: TOP20 Chinese patent medicine products in the terminal digestive system of physical pharmacies in China in 2021 (unit: 100 million yuan Source: Minet) Analyze the cost pressure of traditional Chinese medicine raw materials faced by enterprises
.
3.
Core Raw Materials of Jianwei Xiaoshi Tablets Table 3: Core Materials of Jianwei Xiaoshi Tablets Jianwei Xiaoshi Tablets are digestive aids, used for food accumulation caused by weakness of the spleen and stomach, symptoms such as reluctance to eat , abdominal fullness, indigestion and other symptoms
.
4.
Changes in the core raw materials of Jianwei Xiaoshi Tablet 4: The price of the main raw materials for Jianwei Xiaoshi tablets rose and fell during the period from January 2021 to August 2022.
up to 50%
.
5.
Comments on the raw material market of Jianwei Xiaoshi tablets.
The new production in the production area will continue.
The new production in Guizhou and other places will end in 10 days.
Recently, there have been batches of goods in the market.
The price of small and medium-sized goods is between 52-54 yuan (kg price, the same below), and the price of medium-sized goods is 64-68 yuan
.
This variety has a high market attention, and the market may change in the later period
.
Chenpi, the weather is hot, the market sales volume is large, and the supply of goods is moving well
.
Due to the abundant inventory, the overall price fluctuates little.
The current market price is between 10-11.
5 yuan, the average asking price of Chenpisi is 10-11 yuan, and the better one is 12-13 yuan
.
Yam, the current market supply is in the green and yellow period.
Recently, there are merchants looking for goods.
The supply of small batches is sold smoothly, and the market performance is strong.
The current market price of yam rolls is 12-14 yuan, and the price of three knives is around 17 yuan.
The net price around 20 yuan
.
For malt, due to the fact that there were merchants looking for goods in the early stage, and there was not much stock in the market, the price rose; recently, the supply of goods has been moving in general, the market has been running smoothly, and the merchants have a certain supply of goods for sale.
between yuan
.
6.
Comprehensive evaluation 1.
The raw material pressure test shows that the purchase cost of yam and Radix Ginseng is relatively high.
The pressure test of raw materials shows that the raw materials of Jianwei Xiaoshi tablets mainly come from yam and Radix Ginseng from the perspective of supply pressure; and from the perspective of quality pressure, mainly From tangerine peel and Taizishen
etc.
2.
The rise and fall of the core raw material Prince ginseng has a greater impact on the cost of raw materials.
Although the overall sales of Jianwei Xiaoshi tablets exceed 1.
5 billion yuan, the sales volume is shrinking year by year
.
Judging from the annual report data, in 2021, Jiangzhong Jianwei Xiaoshi Tablets will sell 156 million boxes, 169 million boxes will be sold in 2020, and 177 million boxes will be sold in 2019, a decrease of 6.
63% and 2.
11% respectively compared with 2015, compared with 181 million boxes in 2018.
The performance of sales exceeding 200 million boxes fell by 15.
5%
.
In 2021, although the market price of Prince ginseng once rose to 80 yuan after the new production, the market price dropped to about 50 yuan later, and Jiangzhong Pharmaceutical has a large inventory of raw materials, so it has little impact on the company
.
From the current point of view, the price of the origin of Prince ginseng has been close to the cost of farmers in the previous period, and the market is expected to rebound slightly in the later period.
However, if there is no capital to participate in the speculation, under the background of poor demand, the price of Prince ginseng will not improve this year
.
1.
The terminal digestive system of urban pharmacies has exceeded 14 billion Chinese patent medicines.
2.
Jiangzhong Pharmaceutical is the No.
1 enterprise in the field of Jianwei Xiaoshi .
Comments on the raw material market 6.
Comprehensive evaluation and procurement